Wanhai Xu
- Molecular Biology top 5%
- Biomedical Engineering top 5%
- Cancer Research top 2%
- Biomaterials top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Da‐Yong HouHao WangKeliang WangMan‐Di WangDong‐Bing ChengZeng‐Ying QiaoHongtao LuHong‐Wei An
- Topics
- Nanoplatforms for cancer theranostics (27 papers)Bladder and Urothelial Cancer Treatments (20 papers)Peptidase Inhibition and Analysis (15 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Wanhai Xu
132 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.8k
- Biomedical Engineering 892
- Cancer Research 735
- Biomaterials 669
- Pulmonary and Respiratory Medicine 626
Countries citing papers authored by Wanhai Xu
This map shows the geographic impact of Wanhai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanhai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanhai Xu more than expected).
Fields of papers citing papers by Wanhai Xu
This network shows the impact of papers produced by Wanhai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanhai Xu. The network helps show where Wanhai Xu may publish in the future.
Co-authorship network of co-authors of Wanhai Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Wanhai Xu. A scholar is included among the top collaborators of Wanhai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanhai Xu. Wanhai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 8 | |
| 5 | The promising role of tumor-associated macrophages in the treatment of cancerbreakdown → | 79 |
| 6 | 6 | |
| 7 | 10 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 11 | |
| 11 | 25 | |
| 12 | 52 | |
| 13 | 37 | |
| 14 | 1 | |
| 15 | 51 | |
| 16 | 15 | |
| 17 | 15 | |
| 18 | 50 | |
| 19 | 47 | |
| 20 | 8 |
About Wanhai Xu
Wanhai Xu is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 139 papers that have together received 3.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (27 papers), Bladder and Urothelial Cancer Treatments (20 papers) and Peptidase Inhibition and Analysis (15 papers). The work is most often cited by research in Biomaterials (669 citations), Cancer Research (735 citations) and Molecular Biology (1.8k citations). Wanhai Xu has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Da‐Yong Hou, Hao Wang, Keliang Wang, Man‐Di Wang, Dong‐Bing Cheng, Zeng‐Ying Qiao, Hongtao Lu, Hong‐Wei An, Ziqi Wang and Xingjie Hu. Their work appears in journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.